Smith-Lemli-Opitz Syndrome: Symptoms, Causes, Diagnosis and Treatment

Written by Medicover Team and Medically Reviewed by Dr K Sindhura , Pediatricians



Smith-Lemli-Opitz Syndrome (SLOS) is a rare genetic disorder that affects multiple systems in the body, resulting in a spectrum of physical, developmental, and behavioral abnormalities. Understanding SLOS is crucial for early diagnosis, effective treatment, and better management of the condition.


What are the Symptoms and Warning Signs of Smith-Lemli-Opitz Syndrome?

The symptoms of smith-lemli-opitz syndrome vary widely depending on the severity of the condition. Some children have mild developmental issues, while others experience significant physical and neurological abnormalities.

Recognizing symptoms early allows healthcare providers to offer supportive therapies and monitor complications effectively.

Common Symptoms

  • Delayed growth before and after birth
  • Developmental delays
  • Intellectual disability
  • Feeding difficulties
  • Behavioral challenges
  • Low muscle tone (hypotonia)

Severe Symptoms

  • Congenital heart defects
  • Cleft palate
  • Abnormal facial features
  • Vision or hearing problems
  • Severe developmental impairment
  • Organ abnormalities affecting multiple systems

Are There Different Types of Smith-Lemli-Opitz Syndrome?

Smith-Lemli-Opitz Syndrome is generally considered a single disorder, but its severity varies significantly among affected individuals.

Mild Smith-Lemli-Opitz Syndrome

Individuals with mild forms may have learning difficulties, developmental delays, and subtle physical abnormalities.

  • Milder developmental challenges
  • Near-normal physical growth
  • Better long-term outcomes

Severe Smith-Lemli-Opitz Syndrome

Severe cases involve significant physical malformations, intellectual disability, and organ system complications.

  • Multiple congenital abnormalities
  • Severe developmental delays
  • Higher risk of medical complications

What are the Causes of Smith-Lemli-Opitz Syndrome?

Smith-Lemli-Opitz Syndrome is caused by mutations in the DHCR7 gene, which is responsible for encoding the enzyme 7-dehydrocholesterol reductase. This enzyme plays a crucial role in the biosynthesis of cholesterol.

Mutations in the DHCR7 gene result in reduced or absent activity of this enzyme, leading to impaired cholesterol production and the accumulation of its precursor, 7-dehydrocholesterol (7-DHC). Cholesterol is vital for normal development and function, and its deficiency affects various bodily systems.


When to See a Doctor for Smith-Lemli-Opitz Syndrome?

Infants and children with developmental delays, feeding difficulties, growth problems, or congenital abnormalities should be evaluated by a Clinical Geneticist or Pediatrician. Early diagnosis can help coordinate specialized care and improve long-term developmental outcomes.

You should see a doctor if you have:

  • Delayed growth or developmental milestones
  • Feeding difficulties in infancy
  • Unusual physical features or birth defects

Get medical help immediately if:

  • Severe breathing or feeding problems
  • Signs of heart-related complications
  • Sudden worsening of neurological or developmental symptoms

These could be signs of a serious complication like Smith-Lemli-Opitz Syndrome, which needs urgent care.

Find Pediatricians for Smithlemliopitz Syndrome Treatment Near You


How is Smith-Lemli-Opitz Syndrome Diagnosed?

Smith-Lemli-Opitz Syndrome is diagnosed through a combination of clinical evaluation, genetic testing, and laboratory tests that measure abnormal cholesterol metabolism.

Clinical Evaluation

Diagnosis of smith-lemli-opitz syndrome typically begins with a thorough clinical evaluation, including a detailed medical history and physical examination. Physicians look for characteristic physical features and developmental abnormalities associated with SLOS.

Biochemical Testing

Biochemical testing involves measuring levels of cholesterol and 7-dehydrocholesterol in the blood. Elevated levels of 7-DHC and reduced levels of cholesterol are indicative of SLOS.

Genetic Testing

Genetic testing is the definitive method for diagnosing smith-lemli-opitz syndrome. It involves sequencing the DHCR7 gene to identify mutations. Prenatal genetic testing can also be performed for at-risk pregnancies.


What are the Treatment of Smith-Lemli-Opitz Syndrome?

Treatment for smith-lemli-opitz syndrome focuses on managing symptoms and may include cholesterol supplementation, nutritional support, developmental therapies, and specialized medical care.

Dietary Management

One of the primary treatments for SLOS involves dietary management to increase cholesterol intake. Cholesterol supplements can help alleviate some of the symptoms and improve growth and development. The dosage and form of cholesterol supplementation should be tailored to each individual's needs.

Medications

  • Statins: In some cases, statins (cholesterol-lowering drugs) may be used to reduce the accumulation of 7-DHC. However, their use in SLOS is controversial and should be closely monitored by a healthcare professional.
  • Behavioral Medications: Medications may be prescribed to manage behavioral issues such as hyperactivity, aggression, and mood swings.

Supportive Therapies

  • Physical Therapy: Physical therapy can help improve muscle tone, coordination, and mobility in individuals with SLOS.
  • Occupational Therapy: Occupational therapy focuses on enhancing daily living skills and promoting independence.
  • Speech Therapy: Speech therapy can address communication difficulties and support language development.

Your health is everything - prioritize your well-being today.

schedule appointment Consult Smithlemliopitz Syndrome Doctors Today

What Complications are Associated with Smith-Lemli-Opitz Syndrome?

Smith-Lemli-Opitz Syndrome can lead to developmental delays, intellectual disabilities, feeding difficulties, behavioral challenges, and congenital abnormalities affecting multiple organs.

Neurological Complications

Neurological complications such as seizures, movement disorders, and sensory processing issues are common in individuals with SLOS. These complications can impact cognitive and motor functions, requiring ongoing medical and therapeutic interventions.

Gastrointestinal Complications

Feeding difficulties and gastrointestinal problems, such as reflux and constipation, are prevalent in individuals with SLOS. These issues can lead to poor nutrition and growth, necessitating specialized dietary management and medical interventions.

Cardiovascular Complications

Some individuals with smith-lemli-opitz syndrome may have congenital heart defects, which can range from mild to severe. Regular cardiac evaluations and appropriate medical or surgical interventions are essential for managing these complications.

Behavioral and Psychiatric Complications

Behavioral and psychiatric issues, including anxiety, depression, and obsessive-compulsive behaviors, can significantly impact the daily lives of individuals with SLOS and their families. Comprehensive behavioral and psychiatric care is crucial for addressing these challenges.


What is the Recovery Process for Smith-Lemli-Opitz Syndrome?

Smith-Lemli-Opitz Syndrome is a lifelong condition that requires ongoing medical care and developmental support. Recovery focuses on maximizing functional abilities, managing complications, and improving quality of life.

Regular follow-up with specialists helps monitor growth, development, and organ function while providing support for changing healthcare needs throughout life.

Recovery Includes

  • Long-term developmental therapy
  • Regular pediatric and genetic follow-up
  • Nutritional and cholesterol management
  • Monitoring for organ-related complications
  • Family support and genetic counseling

Frequently Asked Questions

1. What are the symptoms of Smith-Lemli-Opitz syndrome?

Symptoms include intellectual disability, distinctive facial features, and abnormalities in the limbs and genitalia. The severity varies among individuals.

2. What causes Smith-Lemli-Opitz syndrome?

It is caused by mutations in the DHCR7 gene, which leads to a deficiency in cholesterol synthesis, affecting development and growth.

3. How is Smith-Lemli-Opitz syndrome treated?

Treatment is symptomatic and includes cholesterol supplementation, physical therapy, and surgery to correct congenital anomalies.

4. How is Smith-Lemli-Opitz syndrome diagnosed?

Diagnosis involves genetic testing to identify mutations in the DHCR7 gene, along with clinical evaluations of developmental and physical symptoms.

5. What is the prognosis for Smith-Lemli-Opitz syndrome?

The prognosis depends on the severity of the symptoms, but early intervention and ongoing medical care can improve quality of life.

Get A Call From Our Experts

Get A Call From Our Experts

Select a country first
Read this page in:
Book an Appointment Book Appointment Second Opinion Doctor Second Opinion WhatsApp Icon WhatsApp Search for Doctors Find Doctors

Feeling unwell?

Book Doctor Appointment in 30 Sec

Medicover Hospitals India Logo